Exelixis reported $119.25M in Selling and Administration Expenses for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Acadia Pharmaceuticals ACAD:US USD 104.4M 26.29M
Agios Pharmaceuticals AGIO:US USD 32.77M 3.65M
Akebia Therapeutics AKBA:US USD 30.65M 271K
Amgen AMGN:US USD 1.47B 181M
AstraZeneca AZN:LN USD 3.53B 174M
Bayer BAYN:GR EUR 4.43B 347M
Biomarin Pharmaceutical BMRN:US USD 245.74M 28.92M
Bluebird Bio BLUE:US USD 33.4M 3.29M
Bristol Myers Squibb BMY:US USD 2.27B 336M
Cytokinetics CYTK:US USD 53.97M 5.75M
Eisai 4523:JP JPY 92.58B 4.5B
Eli Lilly And LLY:US USD 1.64B 29M
Esperion Therapeutics ESPR:US USD 24.14M 816K
Exelixis EXEL:US USD 119.25M 4.27M
Genmab GEN:DC DKK 921M 251M
Glaxosmithkline GSK:US GBP 2.44B 467M
Immunogen IMGN:US USD 42.06M 8.44M
Macrogenics MGNX:US USD 13.67M 1.68M
Merk MRK:US USD 2.63B 134M
Mirati Therapeutics MRTX:US USD 70.82M 10.02M
Moderna Inc MRNA:US USD 375M 97M
Nektar Therapeutics NKTR:US USD 21.94M 595K
Neurocrine Biosciences NBIX:US USD 182.9M 3.4M
Novartis NOVN:VX USD 3.7B 295M
Pfizer PFE:US USD 4.87B 1.33B
Puma Biotechnology PBYI:US USD 25.04M 1.08M
Seattle Genetics SGEN:US USD 216.1M 5.72M
Takeda 4502:JP JPY 262.3B 13.57B
Ultragenyx Pharmaceutical RARE:US USD 72.85M 3.01M
Xencor XNCR:US USD 12.75M 377K
YTE INCY:US USD 272.82M 6.36M